Cigna Corporation

(New York Stock Exchange)
Back to all articles
Bullish +65

The Cigna Group stock gains focus as 2026 earnings outlook rises

Earnings report Guidance raised Share buyback AI-generated analysis

πŸ“ˆ Cigna Group revenue rose 6% year over year to $73.7 billion in the third quarter ended September 30.

πŸ’° Adjusted earnings from operations reached $2.1 billion, or $7.98 per share, compared to $7.83 a year earlier.

πŸš€ Management lifted the minimum 2026 adjusted EPS outlook to $30.60, an increase of $0.15 from the prior projection.

πŸ₯ Cigna Healthcare adjusted revenue increased 9% to $11.7 billion with pretax adjusted income up 15% to $1.2 billion.

πŸ“‰ Reported net income declined to $1.4 billion due to the absence of a prior-year gain on sale, not operational weakness.

πŸ’Š Evernorth Health Services revenue grew 6% to $63.8 billion, with Specialty and Care Services earnings up 15%.

πŸ“‰ Pharmacy Benefit Services earnings declined amid client contract renewals and strategic investments within the Evernorth segment.

🏦 The company repurchased 1.8 million shares for approximately $500 million through November 4.

🎯 Management narrowed the full-year medical care ratio expectation to 84.2% plus or minus 25 basis points.

πŸ”§ CEO Brian Evanko highlighted progress on the Accelerate to One modernization and productivity initiative.

Bullish Signals
  • Cigna Group lifted its minimum 2026 adjusted EPS outlook to $30.60, an increase of $0.15 from the prior projection.
  • Third-quarter revenue rose 6% year over year to $73.7 billion, demonstrating solid top-line growth.
  • Cigna Healthcare delivered a 9% increase in adjusted revenue and a 15% rise in pretax adjusted income to $1.2 billion.
  • The company repurchased 1.8 million shares for approximately $500 million through November 4, supporting share price.
  • Management narrowed the full-year medical care ratio expectation to 84.2% plus or minus 25 basis points, indicating improved efficiency.
  • Evernorth's Specialty and Care Services earnings increased 15% to $1.1 billion, contributing to overall segment strength.
Risk Factors
  • Reported net income declined to $1.4 billion from $1.9 billion primarily due to the absence of an after-tax gain on a sale that benefited the third quarter of 2025.
  • Evernorth's Pharmacy Benefit Services earnings declined amid client contract renewals and strategic investments within the segment.
Full Analysis
The Cigna Group reported a stronger third-quarter performance, with revenue rising 6 percent year over year to $73.7 billion for the three months ended September 30. Adjusted earnings from operations reached $2.1 billion, or $7.98 per share, driven by improved efficiency and higher net investment income within its Healthcare segment. Management has lifted its minimum full-year adjusted EPS outlook for 2026 to $30.60, an increase of $0.15 from the prior projection. This revised guidance includes anticipated dividends and future share repurchases, signaling confidence in the company's ability to meet its financial targets despite a decline in reported net income due to the absence of a prior-year gain on sale. Cigna Healthcare was the primary driver of earnings improvement, with adjusted revenue up 9 percent to $11.7 billion and pretax adjusted income increasing 15 percent to $1.2 billion. The segment's medical care ratio improved slightly to 85.0 percent, while management narrowed its full-year expected range and raised the pretax adjusted earnings floor by $50 million. Evernorth Health Services generated adjusted revenue of $63.8 billion, up 6 percent from the prior year. While Specialty and Care Services earnings increased 15 percent, Pharmacy Benefit Services earnings declined amid client contract renewals and strategic investments. The company also repurchased 1.8 million shares for approximately $500 million through November 4.